ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2020 and some content may be unavailable. To unlock all content for 2020, please visit the archives.

Abstract: PO0962

Phosphorylated Akt (pAkt) and Myostatin: The Yin and Yang of the Control of Muscle Protein Metabolism in Patients with Diabetic Kidney Disease

Session Information

Category: Diabetic Kidney Disease

  • 602 Diabetic Kidney Disease: Clinical

Authors

  • Picciotto, Daniela, Department of Internal Medicine, Nephrology Division, Policlinico San Martino, Genova, Italy
  • Milanesi, Samantha, Department of Internal Medicine, Nephrology Division, Policlinico San Martino, Genova, Italy
  • Saio, Michela, Department of Internal Medicine, Nephrology Division, Policlinico San Martino, Genova, Italy
  • Brunori, Giuliano, Ospedale Santa Chiara, Trento, Italy
  • Venturelli, Chiara, Ospedale Santa Chiara, Trento, Italy
  • Garibotto, Giacomo, Department of Internal Medicine, Nephrology Division, Policlinico San Martino, Genova, Italy
  • Verzola, Daniela, Department of Internal Medicine, Nephrology Division, Policlinico San Martino, Genova, Italy
Background

Muscle wasting is common in patients with diabetic kidney disease (DKD). Both uremia and diabetes cause inflammation and insulin resistance in skeletal muscle, thus promoting wasting. However, the muscle response in DKD is not known yet. Our aim was to evaluate the intracellular signals controlling protein synthesis and degradation in muscle of patients with DKD. We studied intracellular pAkt (a downward effector of the insulin signal), myostatin (MSTN), p38MAPK, MURF and Atrogin in skeletal muscle of patients with diabetic CKD (DCKD) (n=17, age 69 years±7, eGFR 9 ± 3 ml/min/1.73m2) as compared to non diabetic CKD (NDCKD) (n=32, age 67 years±11, eGFR 7.5 ± 2 ml/min/1.73m2) and controls (C) (n=24, age 67 years±11, eGFR 77 ± 13 ml/min/1.73m2).

Methods

Rectus abdominis muscle biopsies were obtained during the insertion of peritoneal dialysis catheters and during elective surgery for abdominal wall hernias (C). Protein expression (pAkt, MSTN, p38MAPK) was evaluated by immunohistochemistry and western blot, mRNA expression (MSTN, Murf, Atrogin) by rt-PCR.

Results

The expression of pAkt was significantly more downregulated in DCKD as compared to NDCKD and C (P <0.05). MSTN expression was significantly lower in C as compared to DCKD and NDCKD (P<0.05). MSTN mRNA was similary upregulated in DCKD and in NDCKD with respectively a 21- and a 18- fold increase compared to controls. Atrogin and Murf mRNA were both upregulated in DCKD and in NDCKD; in DCKD Murf mRNA presented a 18- and atrogin mRNA a 16- fold increase compared to controls while in NDCKD we found respectively a 12- and a 9- fold increase.

Conclusion

With respect to non DKD, intracellular insulin signaling is particularly blunted in muscle of patients with DKD, while myostatin is similarly overexpressed. In diabetes, the abnormal pAkt levels in conjuction with myostatin overexpression are likely to orchestrate the wasting syndrome.